Applications for Glaucoma Australia’s annual ‘Quinlivan’ Research Grants open on 1 May 2023, with the successful recipient(s) being announced on World Sight Day, 13

Apellis Pharmaceuticals is targeting Australian approval as a priority, as it seeks to expand the availability of its first-in-class treatment for geographic atrophic age-related

Inventor of the procedure of Intense Pulsed Light (IPL) for dry eye disease, US ophthalmologist Dr Rolando Toyos will travel to Australia next month

A unique format has been revealed for the combined O=MEGA23 and fourth World Optometry Congress, which will take place in Melbourne from 8–10 September